XML 106 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders' Equity - Equity Compensation Plan - Narrative (Details) - shares
1 Months Ended 12 Months Ended
Aug. 02, 2021
Sep. 30, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2016
Dec. 31, 2009
Dec. 31, 2021
Oct. 31, 2018
Jun. 30, 2017
Dec. 31, 2015
Jun. 30, 2014
Apr. 30, 2011
Mar. 31, 2011
Stockholders' Equity                              
Granted     0 4,307,599                      
Outstanding stock options     6,438,931 7,036,874         2,954,315            
Dividend yield                              
Stockholders' Equity                              
Annual interest on outstanding balance     0.00%                        
Subsidiaries Stock Incentive Plan                              
Stockholders' Equity                              
Outstanding stock options     31,578                        
Subsidiaries Stock Incentive Plan | CEO | Subsidiaries | Skunkworx Bio, Inc.                              
Stockholders' Equity                              
Granted 10,526                            
Subsidiaries Stock Incentive Plan | CEO | Subsidiaries | Scorpion Biological Services, Inc.                              
Stockholders' Equity                              
Granted 10,638                            
Subsidiaries Stock Incentive Plan | CEO | Subsidiaries | Abacus Biotech, Inc.                              
Stockholders' Equity                              
Granted 10,526                            
Subsidiaries Stock Incentive Plan | CEO | Subsidiaries | Blackhawk Bio Inc.                              
Stockholders' Equity                              
Granted 10,526                            
Subsidiaries Stock Incentive Plan | CFO                              
Stockholders' Equity                              
Granted 2,127                            
2009 Stock Incentive Plan                              
Stockholders' Equity                              
Number of shares authorized               21,739           65,217 21,739
Expiration term               10 years              
Outstanding stock options     625 1,135                      
Common shares available for issuance                           86,957  
2014 Stock Option Plan                              
Stockholders' Equity                              
Number of shares authorized                         50,000    
Stock Incentive Plan, shares authorized increased                       60,000      
Outstanding stock options     16,750           17,385            
2009 and 2014 Plans                              
Stockholders' Equity                              
Granted             300,000                
2017 Stock Option Plan                              
Stockholders' Equity                              
Number of shares authorized                     500,000        
Outstanding stock options     27,163 31,018                      
2018 Stock Option Plan                              
Stockholders' Equity                              
Number of shares authorized                   571,428          
Increase in the number of shares available for grant       5,000,000 2,142,857 571,428                  
Outstanding stock options     6,362,805 6,955,758                      
2021 Stock Option Plan                              
Stockholders' Equity                              
Common shares available for issuance     785,196                        
2021 Employee Stock Option Plan                              
Stockholders' Equity                              
Number of shares authorized   500,000                          
Common shares available for issuance     425,889 488,336                      
Share based payment award discount from market price on purchase date   15.00%                          
Share based payment award discount from market price on offering date   85.00%